GlassScriptPhysician profile
Neel K Dharia
NPI 1760458103
$133,853.64
in general payments reported to CMS, 2019-2025
92 companies · $28K in 2025
The $28K reported for 2025 was more than what 94% of Hematology & Oncology providers received nationally (typical 2025 total: $686).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $29K · 2020: $11K · 2021: $13K · 2022: $20K · 2023: $19K · 2024: $14K · 2025: $28K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $20K · Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $17K · Food and Beverage: $16K · Travel and Lodging: $4,533 · Honoraria: $2,583 · Education: $176 · Gift: $19.74.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $20,475.00 |
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $16,675.00 |
| Food and Beverage | $15,869.01 |
| Travel and Lodging | $4,533.16 |
| Honoraria | $2,582.50 |
| Education | $176.42 |
| Gift | $19.74 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Bayer Healthcare Pharmaceuticals INC. | $17,677.71 | 2019-2025 | |
| Daiichi Sankyo INC. | $13,245.27 | 2020-2025 | Enhertu, Injectafer, Vanflyta |
| Jazz Pharmaceuticals INC. | $11,922.41 | 2020-2025 | |
| Janssen Biotech, INC. | $8,001.25 | 2019-2025 | Rybrevant, Darzalex, Erleada |
| Kite Pharma, INC. | $7,871.86 | 2020-2025 | Yescarta |
| Celgene Corporation | $7,276.81 | 2019-2025 | Reblozyl, Opdualag, Opdivo |
| Rigel Pharmaceuticals, INC. | $6,961.59 | 2019-2025 | Rezlidhia, Tavalisse, Gavreto |
| Ipsen Biopharmaceuticals, INC | $6,812.47 | 2019-2025 | Onivyde |
| Astrazeneca Pharmaceuticals LP | $5,593.51 | 2019-2025 | Imfinzi, Enhertu, Lynparza |
| Gilead Sciences, INC. | $4,629.37 | 2019-2025 | Trodelvy |
| Abbvie INC. | $4,284.44 | 2019-2025 | Epkinly, Creon, Venclexta |
| Janssen Scientific Affairs, LLC | $4,247.87 | 2019-2023 | Rybrevant |
| Novartis Pharmaceuticals Corporation | $2,949.49 | 2019-2025 | |
| Pfizer INC. | $2,734.97 | 2019-2025 | |
| Onmark, INC. | $2,605.10 | 2025 |
Show all 92 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Takeda Pharmaceuticals U.S.A., INC. | $2,405.66 | 2019-2025 | Iclusig, Alunbrig, Ninlaro |
| Deciphera Pharmaceuticals INC. | $2,231.15 | 2022-2025 | Qinlock |
| Karyopharm Therapeutics INC. | $2,064.48 | 2021-2024 | Xpovio |
| Beigene USA, INC. | $1,851.66 | 2022-2024 | Brukinsa |
| Seagen INC. | $1,843.27 | 2019-2023 | Tukysa, Padcev, Adcetris |
| Exelixis INC. | $1,672.12 | 2021-2025 | Cabometyx |
| E.R. Squibb & Sons, L.L.C. | $1,281.33 | 2019-2025 | Opdivo, Opdualag, Augtyro |
| Genentech USA, INC. | $1,055.58 | 2019-2025 | Polivy, Tecentriq, Alecensa |
| Merck Sharp & Dohme LLC | $1,013.63 | 2019-2025 | Keytruda, Welireg, Lynparza |
| Geron Corporation | $792.79 | 2025 | Rytelo |
| Genzyme Corporation | $755.39 | 2019-2025 | |
| Eisai INC. | $752.82 | 2019-2025 | |
| Amgen INC. | $673.76 | 2019-2023 | Lumakras, Kyprolis, Vectibix |
| Astellas Pharma US INC | $641.91 | 2019-2025 | Vyloy, Xospata, Padcev |
| Regeneron Healthcare Solutions, INC. | $639.49 | 2021-2025 | Libtayo |
| Glaxosmithkline, LLC. | $631.88 | 2020-2025 | Jemperli, Ojjaara, Zejula |
| Beigene, LTD. | $450.00 | 2020 | |
| Incyte Corporation | $441.87 | 2019-2025 | Jakafi, Monjuvi, Pemazyre |
| Pharmacyclics LLC, An Abbvie Company | $428.24 | 2019-2023 | Imbruvica, Epkinly |
| Array Biopharma INC | $309.64 | 2019-2025 | Mektovi, Braftovi, Lorbrena |
| Janssen Pharmaceuticals, INC | $293.76 | 2019-2023 | Xarelto |
| Caris Mpi, INC. | $289.16 | 2025 | Mi Cancer Seek |
| Alexion Pharmaceuticals, INC. | $247.30 | 2019-2025 | Ultomiris |
| Lilly USA, LLC | $241.53 | 2019-2025 | Verzenio, Jaypirca, Retevmo |
| Adc Therapeutics America, INC. | $228.90 | 2022-2025 | |
| Blueprint Medicines Corporation | $228.29 | 2020-2025 | Ayvakit |
| Servier Pharmaceuticals LLC | $220.87 | 2021-2025 | |
| Beone Medicines USA, INC. | $214.79 | 2025 | Tevimbra, Brukinsa |
| Emd Serono, INC. | $187.16 | 2020-2025 | Bavencio, Tepmetko |
| Puma Biotechnology, INC. | $179.88 | 2019-2025 | |
| Aveo Pharmaceuticals, INC. | $167.53 | 2022-2025 | Fotivda |
| Mirati Therapeutics, INC. | $147.03 | 2023-2024 | Krazati |
| Sun Pharmaceutical Industries INC. | $136.61 | 2019-2023 | Yonsa, Odomzo |
| Boehringer Ingelheim Pharmaceuticals, INC. | $130.84 | 2019-2025 | |
| Clovis Oncology, INC. | $129.33 | 2019-2022 | |
| Sirtex Medical INC | $128.19 | 2025 | Sir-Spheres Microspheres |
| Sumitomo Pharma America, INC. | $126.80 | 2023-2025 | Orgovyx |
| Springworks Therapeutics, INC. | $120.15 | 2024-2025 | Ogsiveo |
| Sanofi-Aventis U.S. LLC | $119.69 | 2020-2023 | |
| Taiho Oncology, INC. | $102.88 | 2023-2025 | |
| Sobi, INC | $98.44 | 2024-2025 | |
| Organon LLC | $90.14 | 2021-2022 | |
| Morphosys, US INC. | $81.63 | 2022-2023 | Monjuvi |
| Stemline Therapeutics INC. | $75.95 | 2023-2024 | Orserdu |
| Intuitive Surgical, INC. | $68.88 | 2022 | |
| Epizyme, INC. | $68.37 | 2021-2022 | |
| Agios Pharmaceuticals, INC. | $61.03 | 2019-2023 | Pyrukynd |
| Myovant Sciences INC. | $55.96 | 2021-2022 | |
| Tersera Therapeutics LLC | $55.53 | 2022-2024 | Zoladex |
| Dova Pharmaceuticals | $52.27 | 2021 | |
| Legend Biotech USA INC. | $52.08 | 2025 | Carvykti |
| Kyowa Kirin, INC. | $48.88 | 2019-2025 | |
| Adaptive Biotechnologies Corporation | $46.50 | 2025 | Clonoseq |
| G1 Therapeutics, INC. | $43.40 | 2022-2023 | Cosela |
| Davol INC. | $41.22 | 2024 | Progel Applicator Spray Tips |
| Global Blood Therapeutics, INC. | $38.48 | 2022 | |
| Lexicon Pharmaceuticals, INC. | $38.40 | 2019 | |
| Chiesi USA, INC. | $37.23 | 2023-2025 | Ferriprox |
| Fennec Pharmaceuticals, INC. | $33.79 | 2024 | Pedmark |
| Emmaus Medical, INC. | $30.94 | 2022-2023 | Endari |
| Mylan Institutional INC. | $30.57 | 2019-2021 | |
| Verastem, INC. | $24.97 | 2019-2020 | |
| Iovance Biotherapeutics, INC. | $23.98 | 2025 | Amtagvi |
| Amneal Pharmaceuticals LLC | $23.63 | 2025 | Alymsys |
| Pharmaessentia USA Corporation | $23.10 | 2025 | Besremi |
| Mayne Pharma Commercial LLC | $22.89 | 2022 | |
| Coherus Oncology, INC. | $21.69 | 2024 | |
| Tesaro, INC. | $21.35 | 2019 | |
| Spectrum Pharmaceuticals INC. | $21.07 | 2019 | |
| Cti Biopharma Corp. | $20.26 | 2023 | Vonjo |
| Nestle Healthcare Nutrition INC. | $18.86 | 2021 | |
| Recordati_rare_diseases_inc. | $18.49 | 2025 | Enjaymo |
| Tempus Ai, INC | $18.17 | 2024 | |
| Eusa Pharma (US) LLC | $15.07 | 2022 | |
| Shorla Oncology INC. | $13.56 | 2025 | |
| Aurobindo Pharma USA, INC. | $13.00 | 2019 | |
| Abbott Laboratories | $12.38 | 2023 | Proclaim |
Drugs and devices associated with these payments
Zepzelca $12KEnhertu $8,143Onivyde $6,648Rybrevant $3,274Imfinzi $2,114Cabometyx $1,599Padcev $1,397Rytelo $793Reblozyl $591Epkinly $535Keytruda $482Libtayo $480Imbruvica $470Lenvima $427Orgovyx $330Brukinsa $310Xtandi $306Mi Cancer Seek $289Polivy $268Opdivo $254Xarelto $247Tukysa $246Elrexfio $238Kisqali $235Jemperli $217Ibrance $210Venclexta $206Talzenna $206Lynparza $195Braftovi $185Mektovi $185Opdualag $176Fabhalta $176Jakafi $171Ayvakit $157Rezlidhia $156Tavalisse $156Darzalex $154Adcetris $153Ojjaara $150Erleada $149Krazati $147Ultomiris $146Zejula $144Lorbrena $143Jevtana $138Tecentriq $138Verzenio $136Scemblix $134Welireg $129Sir-Spheres Microspheres $128Sarclisa $126Balversa $124Xalkori $123Ogsiveo $120Yescarta $119Vonjo $119Tibsovo $117Gavreto $115Tevimbra $113Fotivda $111Injectafer $111Vitrakvi $111Enjaymo $107Trodelvy $105Lonsurf $103Inqovi $103Akeega $102Monjuvi $97.62Oxbryta $92.21Vyloy $91.27Alecensa $90.55Cablivi $88.48Carvykti $87.71Pluvicto $82.84Bavencio $82.49Qinlock $81.15Jaypirca $80.51Comirnaty $80.18Phesgo $79.67Xospata $78.36Inlyta $76.70Orserdu $75.95Tabrecta $73.79Tecvayli $71.62Ziihera $69.29Rozlytrek $64.57Lunsumio $62.50Retevmo $61.22Promacta $57.47Tasigna $56.46Stivarga $52.98Yonsa $50.86Altuviiio $50.55Iclusig $50.10Itovebi $49.96Alunbrig $47.59Columvi $47.38Lutathera $46.83Talvey $46.69
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Neel Dharia listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.